Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Triacetin |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Boric acid topical agent |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Acrisorcin (substance) |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amphotericin A |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylrosaniline |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sulconazole |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Terbinafine (substance) |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Econazole (substance) |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Undecylenic acid and undecylenate salt |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing nystatin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing naftifine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole [infections] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely miconazole 25 milligram/1 gram conventional release oral gel (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin [systemic] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 100000 unit/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 500,000units tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin GF/LF/SF 100,000units/mL suspension (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole [genital] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely miconazole nitrate 20 milligram/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 100mg pessary (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 100mg/2% pessary+cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin [gynecological use] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 25000 unit/1 gram conventional release vaginal cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100,000units pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol 10 mg/mL and flumetasone pivalate 200 microgram/mL ear drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole [oropharyngeal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin [mouth-no preps] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin [mouth] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100,000units pastille |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ketoconazole 20 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 20 mg/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 2% dusting powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely miconazole nitrate 1.6 milligram/1 gram conventional release powder for cutaneous spray (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin [skin] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 100000 unit/1 gram and tolnaftate 10 milligram/1 gram conventional release cutaneous cream (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorhexidine hydrochloride 10 mg/g and nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100000 unit/g cutaneous cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100000 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole 1% preservative-free eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical nystatin (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing miconazole in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing miconazole in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Topical miconazole |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 1.2g pessary (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 8% solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxiconazole nitrate 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxiconazole nitrate 1% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely nystatin 500000 unit/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 1 million unit oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 200000 unit oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol+hydrocortisone 3%/0.5% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol+hydrocortisone 3%/1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol+hydrocortisone 3%/1% ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naftifine hydrochloride 1% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely natamycin 50 milligram/1 milliliter conventional release eye suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100 unit/g cutaneous ointment |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Naftifine hydrochloride 1.0% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 7.7mL lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 7.7mg gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox olamine 1% cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Nystatin 100 unit/mg cutaneous powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole 20mg/g cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200 mg vaginal pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg/sup pessary |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natamycin 5% suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely ciclopirox 80 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 200mg cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole nitrate 2%wv cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 7.7mg lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ciclopirox 0.77% gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone + pramoxine hydrochloride 3%ww/1%ww/0.5%ww |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 3%ww/0.5%ww cream |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 3%ww/0.5%ww lotion |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol + hydrocortisone 30mg/10mg |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tolnaftate |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylrosanilinium chloride |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Haloprogin (substance) |
Is a |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ketoconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Miconazole-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Clioquinol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxiconazole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing sodium propionate (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Skin antifungal agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Carbol-fuchsin topical solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing ciclopirox (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing natamycin in ocular dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Skin antifungal agent |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|